Local botulinum toxin‑A injections for children with dysfunctional voiding or persistent bedwetting
Official title: Evaluation of Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis
Run by Tanta University · NCT07523477 · Data updated 2026-11-12
This will try a local injection of botulinum toxin‑A to see if it helps children with dysfunctional voiding or persistent nighttime bedwetting who haven't improved with standard treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 64 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, El-Gharbia) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07523477 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children under 18 with dysfunctional voiding or refractory nocturnal enuresis who have not improved with standard treatments and who are medically fit for anesthesia may be eligible.
✕Probably not a fit
Children with bleeding disorders, neuromuscular diseases (e.g., myasthenia gravis), active urinary tract infection, or those unfit for anesthesia are excluded and unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional protocol delivers botulinum toxin‑A injections to the lower urinary tract of children with dysfunctional voiding or refractory monosymptomatic nocturnal enuresis who have not responded to conventional therapy. The procedure is performed under anesthesia and excludes children with bleeding disorders, neuromuscular disease, active urinary infection, or those unfit for anesthesia. Botulinum toxin‑A acts by inhibiting neurotransmitter release and modulating sensory receptors in the bladder and urethral sphincter to reduce involuntary contractions and improve emptying. The trial is conducted at Tanta University in Tanta, El‑Gharbia, Egypt.
Why it matters
Potential benefit: If successful, the injections could reduce involuntary sphincter contractions and bedwetting episodes, lowering post‑void residuals and improving daytime and nighttime urinary control.
How similar studies have gone: Botulinum toxin‑A has shown symptomatic benefit in other pediatric bladder and sphincter dysfunction studies, though data specifically for refractory nocturnal enuresis are more limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children \< 18 years. * Both sexes. * Patients with refractory nocturnal enuresis or dysfunctional voiding who are not responding to the traditional treatment. Exclusion Criteria: * Bleeding disorders. * Neuromusclar disorder(e.g.,Myasthenia gravis). * Patients who are not fit for anaesthesia. * Active urinary tract infection (UTI).
Where it's running
-
Tanta University
Tanta, El-Gharbia, Egypt Recruiting
Study contacts
- Study coordinator: Ahmad M Shalaby, MBBCH
- Email: Ahmed.m.shalaby97@gmail.com
- Phone: 00201021847979
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Liposomal bupivacaine to reduce pain after VATS
This test will see if a long‑acting liposomal bupivacaine injection at the incision eases postoperative pain for adults having VATS lung surgery.
-
Oral N-Acetylcysteine for Diabetic Macular Edema
This study tests whether taking N-acetylcysteine by mouth can help people with center-involving diabetic macular edema who don’t yet need anti-VEGF therapy.
-
3D-Printed versus Conventional Palatal Cribs for Tongue Thrust in Children
This study tests whether a 3D-printed cobalt-chromium palatal crib works better than a traditional soldered stainless steel crib to help kids stop tongue thrusting.
-
Dia-Root Bio MTA vs MTA Plus forIndirect Pulp Capping in Young Permanent Molars
This trial tests whether Dia-Root Bio MTA works as an indirect pulp cap in kids’ first permanent molars better or similar to standard MTA Plus.
-
Nanohydroxyapatite vs Fluoride Varnish for MIH Front Teeth
This trial tests whether a nanohydroxyapatite varnish can remineralize MIH-affected front teeth in 8–11 year-olds as effectively as a standard 5% fluoride varnish.
-
Lactium premedication to see if it prevents emergence agitation after adenotonsillectomy
A preoperative dose of Lactium is tested to see if it prevents emergence agitation in children after adenotonsillectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.